Purine signaling pathways mainly include adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and adenosine (ADO), which act on purinergic receptors, prevent thrombosis, and inhibit inflammation, and are potential therapeutic targets for ischemic stroke [34]. The gene discussed is ADO; the disease is ischemic stroke.